Literature DB >> 1371343

Methylation of an alpha-foetoprotein gene intragenic site modulates gene activity.

K Opdecamp1, M Rivière, M Molné, J Szpirer, C Szpirer.   

Abstract

By comparing the methylation pattern of Mspl/Hpall sites in the 5' region of the mouse alpha-foetoprotein (AFP) gene of different cells (hepatoma cells, foetal and adult liver, fibroblasts), we found a correlation between gene expression and unmethylation of a site located in the first intron of the gene. Other sites did not show this correlation. In transfection experiments of unmethylated and methylated AFP-CAT chimeric constructions, we then showed that methylation of the intronic site negatively modulates expression of CAT activity. We also found that a DNA segment centered on this site binds nuclear proteins; however methylation did not affect protein binding.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371343      PMCID: PMC310351          DOI: 10.1093/nar/20.2.171

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  58 in total

1.  CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation.

Authors:  S M Iguchi-Ariga; W Schaffner
Journal:  Genes Dev       Date:  1989-05       Impact factor: 11.361

2.  Glucocorticoid receptor binding and activation of a heterologous promoter by dexamethasone by the first intron of the human growth hormone gene.

Authors:  E P Slater; O Rabenau; M Karin; J D Baxter; M Beato
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

3.  Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and alpha 1-antitrypsin genes.

Authors:  R H Costa; D R Grayson; J E Darnell
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

4.  Effect of in vitro DNA methylation on beta-globin gene expression.

Authors:  J Yisraeli; D Frank; A Razin; H Cedar
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

5.  Factors involved in control of tissue-specific expression of albumin gene.

Authors:  S Cereghini; M Raymondjean; A G Carranca; P Herbomel; M Yaniv
Journal:  Cell       Date:  1987-08-14       Impact factor: 41.582

6.  Interaction of protein with DNA in vitro.

Authors:  L Hennighausen; H Lubon
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

Review 7.  DNA methylation and gene activity.

Authors:  H Cedar
Journal:  Cell       Date:  1988-04-08       Impact factor: 41.582

8.  Genomic footprinting reveals cell type-specific DNA binding of ubiquitous factors.

Authors:  P B Becker; S Ruppert; G Schütz
Journal:  Cell       Date:  1987-11-06       Impact factor: 41.582

9.  Methylation of the mouse hprt gene differs on the active and inactive X chromosomes.

Authors:  L F Lock; D W Melton; C T Caskey; G R Martin
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

10.  Reactivation of the methylation-inhibited late E2A promoter of adenovirus type 2 by a strong enhancer of human cytomegalovirus.

Authors:  D Knebel-Mörsdorf; S Achten; K D Langner; R Rüger; B Fleckenstein; W Doerfler
Journal:  Virology       Date:  1988-09       Impact factor: 3.616

View more
  3 in total

1.  MyoD1 promoter autoregulation is mediated by two proximal E-boxes.

Authors:  J M Zingg; G Pedraza-Alva; J P Jost
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

2.  Identification of an enhancer and an alternative promoter in the first intron of the alpha-fetoprotein gene.

Authors:  S Scohy; P Gabant; C Szpirer; J Szpirer
Journal:  Nucleic Acids Res       Date:  2000-10-01       Impact factor: 16.971

3.  Transcription factor interactions and chromatin modifications associated with p53-mediated, developmental repression of the alpha-fetoprotein gene.

Authors:  Thi T Nguyen; Kyucheol Cho; Sabrina A Stratton; Michelle Craig Barton
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.